HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
CORT
Corcept Therapeutics Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $4.90B
Market Cap
$4.90B
Enterprise Val
$4.54B
P/E Ratio
49.96
P/B Ratio
7.57
Trailing PEG (1Y)
-2.90
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$647.8M
Gross Margin98.74%
Profit Margin98.74%
Return on Equity15.11%
Return on Assets11.87%
Current Ratio2.92
Debt/Equity0.01
LT Debt/Equity0.01
Revenue Per Share1.92

Income Statement

Dec 31, 2025
Revenue$202.1M
Cost of Revenue$2.5M
Gross Profit$199.6M
R&D$64.9M
SG&A$130.2M
Operating Expenses$195.1M
Operating Income$4.5M
Interest Expense-$5.4M
Tax Expense-$14.4M
Net Income$23.9M
EPS (Basic)$0.24
EPS (Diluted)$0.20
EBIT$4.1M
EBITDA$4.6M
Consolidated Income$24.3M
Non-Controlling Interests$384.0K

Balance Sheet

Dec 31, 2025
Cash & Equivalents$120.5M
Accounts Receivable$59.8M
Inventory$24.0M
Current Assets$485.5M
LT Investments$160.3M
Property, Plant & Equipment$6.5M
Intangibles$0.00
Non-Current Assets$351.2M
Total Assets$836.7M
Accounts Payable$40.4M
Current Debt$1.1M
Current Liabilities$166.1M
LT Debt$5.0M
Non-Current Liabilities$22.8M
Total Liabilities$188.8M
Total Debt$6.1M
Retained Earnings$643.4M
Shareholder Equity$647.8M
Shares Outstanding105,188,217

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$38.4M
Investing Cash Flow-$11.8M
Financing Cash Flow-$31.2M
CapEx-$50.0K
Free Cash Flow$38.4M
Depreciation & Amort.$482.0K
Stock-Based Comp$20.8M
Acquisitions / Disposals$0.00
Investment Activity-$11.8M
Debt Issued/Repaid$0.00
Equity Issued/Repaid-$31.2M
Dividends Paid$0.00
Net Change in Cash-$4.6M
Data cached · Meta live · Daily live · Statements live · TTL 24h